Cystic Fibrosis Research Grant

Applications must address important and timely issues surrounding the pathophysiology, diagnosis, management, and/or treatment of cystic fibrosis. Projects must also demonstrate how they will have a positive impact on the lung health of a community.

Grant Amount:

$50,000 1-year grant: October 1, 2024, through October 31, 2025.

Eligibility

_You can learn more about this opportunity by visiting the funder's website._

• CHEST membership is required at the time of application.
• Applicants must be licensed physicians. Physicians-in-training (residents or fellows), other health care professionals, or clinical researchers with relevant experience will also be accepted.
  • Although applicants may be at later career stages, special consideration will be given to young investigators and applicants in early stages of their career.
  • “Young Investigators” and “Early Career” are defined as residents/fellows/other health care researchers with relevant experience or practicing physicians who have completed their post-graduate training within the last 7 years.
• Teams are encouraged to apply but must have a representative to serve as the Principal Investigator (PI) who will apply as an individual and will receive recognition, if awarded.
• Institutional review board approval must be sought/received for all projects to ensure protection of subjects.
• Not-for-profit organizations and institutions are eligible to apply.

_You must be a member of this organization to apply for this award - become a member._

Ineligibility

• Active CHEST grantees, including those with active no cost extension (NCE) requests.
• Members of the CHEST Board of Regents or Board of Advisors, as well as their family members.
• Indirect costs will not be covered.
• PI salaries will not be supported.
• Higher-level translational research project preferred (T1-T5); basic (cellular or animal) research projects will not be considered.